National Institute for Occupational Safety and Health Draft Immediately Dangerous to Life or Health (IDLH) Value Profile for Peracetic Acid (CAS #79-21-0), 53147-53148 [2016-19051]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 155 / Thursday, August 11, 2016 / Notices
Governors not later than September 6,
2016.
A. Federal Reserve Bank of Atlanta
(Chapelle Davis, Assistant Vice
President) 1000 Peachtree Street NE.,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. Pinnacle Financial Corporation,
Elberton, Georgia, to acquire 100
percent of the outstanding voting stock
of Independence Bank of Georgia,
Braselton, Georgia.
Board of Governors of the Federal Reserve
System, August 5, 2016.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
Board of Governors of the Federal Reserve
System, August 5, 2016.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2016–19059 Filed 8–10–16; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL RESERVE SYSTEM
[FR Doc. 2016–19060 Filed 8–10–16; 8:45 am]
sradovich on DSK3GMQ082PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Savings and Loan Holding
Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Home Owners’ Loan Act
(12 U.S.C. 1461 et seq.) (HOLA),
Regulation LL (12 CFR part 238), and
Regulation MM (12 CFR part 239), and
all other applicable statutes and
regulations to become a savings and
loan holding company and/or to acquire
the assets or the ownership of, control
of, or the power to vote shares of a
savings association and nonbanking
companies owned by the savings and
loan holding company, including the
companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the HOLA (12 U.S.C. 1467a(e)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 10(c)(4)(B) of the
HOLA (12 U.S.C. 1467a(c)(4)(B)). Unless
otherwise noted, nonbanking activities
will be conducted throughout the
United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than September 6,
2016.
A. Federal Reserve Bank of Cleveland
(Nadine Wallman, Vice President) 1455
VerDate Sep<11>2014
17:44 Aug 10, 2016
Jkt 238001
East Sixth Street, Cleveland, Ohio
44101–2566. Comments can also be sent
electronically to
Comments.applications@clev.frb.org:
1. Tinka K. Powell 2016 Family Trust;
Tinka K. Powell 2016 Family Trust fbo
John W. Powell; Tinka K. Powell 2016
Family Trust fbo Mark W. Powell; Tinka
K. Powell 2016 Family Trust fbo Ryan J.
Powell; and James R. Powell 2016
Family Trust, all of Dayton, Ohio all to
become savings and loan holding
companies by acquiring of more than 25
percent of the total equity of Liberty
Capital, Inc., Wilmington, Ohio, and
thereby acquire control of Liberty
Savings Bank, FSB, Wilmington, Ohio.
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2016–0074; NIOSH
156–B]
National Institute for Occupational
Safety and Health Draft Immediately
Dangerous to Life or Health (IDLH)
Value Profile for Peracetic Acid (CAS
#79–21–0)
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of draft document for
public comment.
AGENCY:
On May 1, 2015, the Director
of the National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
published a notice in the Federal
Register [80 FR 24930] announcing the
availability of and a request for
comments for the draft immediately
dangerous to life or health (IDLH) values
and support technical documents,
entitled IDLH Values Profiles, for 14
chemicals. Written comments were to be
received before the end of the comment
period on June 30, 2015. Due to
subsequent requests from the public,
this Notice announces that NIOSH is
seeking further comments on the draft
IDLH Value Profile for peracetic acid
(CAS #79–21–0) https://www.cdc.gov/
SUMMARY:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
53147
niosh/docket/review/docket156a/pdfs/
g1-013-peracetic-acid-cas-79-21-0.pdf
for an additional 60 days.
DATES: Electronic or written comments
on the draft IDLH Value Profile for
peracetic acid must be received by
October 11, 2016.
ADDRESSES: You may submit comments,
identified by CDC–2016–0074 and
docket number NIOSH 156–B, by either
of the two following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, OH 45226.
Instructions: All information received
in response to this notice must include
the agency name and docket number
[CDC–2016–0074; NIOSH 156–B]. All
relevant comments received will be
posted without change to
www.regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: G.
Scott Dotson, NIOSH, Education and
Information Division, Robert A. Taft
Laboratories, 1090 Tusculum Avenue,
MS C–32, Cincinnati, Ohio 45226,
telephone (513) 533–8540 (not a toll free
number).
SUPPLEMENTARY INFORMATION: The
proposed IDLH value and draft IDLH
Value Profile for peracetic acid is based
on the process outlined in the NIOSH
Current Intelligence Bulletin 66—
Derivation of Immediately Dangerous to
Life or Health (IDLH) Values https://
www.cdc.gov/niosh/docs/2014-100/
pdfs/2014-100.pdf. The draft IDLH
Value Profile was developed to provide
the scientific rationale behind the
derivation of the proposed IDLH value
for peracetic acid. This includes a
detailed summary of the health hazards
of acute exposure to high airborne
concentrations of peracetic acid and the
rationale for the proposed IDLH value
for peracetic acid.
To facilitate the review of this draft
document, NIOSH requests that the
following questions be taken into
consideration:
1. Does this document clearly outline
the health hazards associated with acute
(or short-term) exposures to peracetic
acid? If not, what specific information is
missing from the document?
2. Are the rationale and logic behind
the derivation of an IDLH value for
peracetic acid clearly explained? If not,
what specific information is needed to
clarify the basis of the IDLH value?
E:\FR\FM\11AUN1.SGM
11AUN1
53148
Federal Register / Vol. 81, No. 155 / Thursday, August 11, 2016 / Notices
3. Are the conclusions supported by
the data?
4. Are the tables clear and
appropriate?
5. Is the document organized
appropriately? If not, what
improvements are needed?
6. Are you aware of any scientific data
reported in governmental publications,
databases, peer-reviewed journals, or
other sources that should be included
within this document?
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2016–19051 Filed 8–10–16; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0115]
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by September
12, 2016.
SUMMARY:
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A63, 11601 Landsdown
St., North Bethesda, MD 20852,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
FOR FURTHER INFORMATION CONTACT:
Manufactured Food Regulatory
Program Standards—OMB Control
Number 0910–0601—Extension
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Manufactured
Food Regulatory Program Standards
AGENCY:
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0601. Also
include the FDA docket number found
in brackets in the heading of this
document.
ADDRESSES:
In the Federal Register of July 20,
2006 (71 FR 41221), FDA announced the
availability of a draft document entitled
‘‘Manufactured Food Regulatory
Program Standards (MFRPS).’’ These
program standards have since been
finalized and updated multiple times.
The current standards are the
framework that States should use to
design and manage their manufactured
food programs. The current version
expires on September 30, 2016, and
FDA is proposing to update and submit
for issuance with a new expiration date.
The current and proposed versions of
the standards are available at the docket
number identified in brackets at the
heading of this document. Persons with
access to the Internet may submit email
requests for a single copy of the draft
manufactured food standards to OPORA@fda.hhs.gov. There are 42 State
programs enrolled, in which each State
may receive up to $300,000 each year
for a period of 5 years provided there is
significant conformance with the 10
standards.
In the first year of implementing the
program standards, the State program
conducts a baseline self-assessment to
determine if it meets the elements of
each standard. The State program
should use the worksheets and forms
contained in the draft program
standards; however, it can use alternate
forms that are equivalent. The State
program maintains the documents and
verifies records required for each
standard. The information contained in
the documents must be current and fitfor-use. If the State program fails to meet
all program elements and
documentation requirements of a
standard, it develops a strategic
improvement plan that includes the
following: (1) The individual program
element or documentation requirement
of the standard that was not met, (2)
improvements needed to meet the
program element or documentation
requirement of the standard, and (3)
projected completion dates for each
task.
In the Federal Register of February
12, 2016 (81 FR 7544), FDA published
a 60-day notice requesting public
comment on the proposed collection of
information. We received two
comments. However, these comments
did not address the information
collection.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Respondent
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
Total hours
State Departments of Agriculture or Health ........................
42
1
42
376
15,792
sradovich on DSK3GMQ082PROD with NOTICES
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Sep<11>2014
17:44 Aug 10, 2016
Jkt 238001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
E:\FR\FM\11AUN1.SGM
11AUN1
]]>Agencies
[Federal Register Volume 81, Number 155 (Thursday, August 11, 2016)]
[Notices]
[Pages 53147-53148]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19051]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number CDC-2016-0074; NIOSH 156-B]
National Institute for Occupational Safety and Health Draft
Immediately Dangerous to Life or Health (IDLH) Value Profile for
Peracetic Acid (CAS #79-21-0)
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of draft document for public comment.
-----------------------------------------------------------------------
SUMMARY: On May 1, 2015, the Director of the National Institute for
Occupational Safety and Health (NIOSH) of the Centers for Disease
Control and Prevention (CDC), published a notice in the Federal
Register [80 FR 24930] announcing the availability of and a request for
comments for the draft immediately dangerous to life or health (IDLH)
values and support technical documents, entitled IDLH Values Profiles,
for 14 chemicals. Written comments were to be received before the end
of the comment period on June 30, 2015. Due to subsequent requests from
the public, this Notice announces that NIOSH is seeking further
comments on the draft IDLH Value Profile for peracetic acid (CAS #79-
21-0) https://www.cdc.gov/niosh/docket/review/docket156a/pdfs/g1-013-peracetic-acid-cas-79-21-0.pdf for an additional 60 days.
DATES: Electronic or written comments on the draft IDLH Value Profile
for peracetic acid must be received by October 11, 2016.
ADDRESSES: You may submit comments, identified by CDC-2016-0074 and
docket number NIOSH 156-B, by either of the two following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: National Institute for Occupational Safety and
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati,
OH 45226.
Instructions: All information received in response to this notice
must include the agency name and docket number [CDC-2016-0074; NIOSH
156-B]. All relevant comments received will be posted without change to
www.regulations.gov, including any personal information provided. For
access to the docket to read background documents or comments received,
go to www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: G. Scott Dotson, NIOSH, Education and
Information Division, Robert A. Taft Laboratories, 1090 Tusculum
Avenue, MS C-32, Cincinnati, Ohio 45226, telephone (513) 533-8540 (not
a toll free number).
SUPPLEMENTARY INFORMATION: The proposed IDLH value and draft IDLH Value
Profile for peracetic acid is based on the process outlined in the
NIOSH Current Intelligence Bulletin 66--Derivation of Immediately
Dangerous to Life or Health (IDLH) Values https://www.cdc.gov/niosh/docs/2014-100/pdfs/2014-100.pdf. The draft IDLH Value Profile was
developed to provide the scientific rationale behind the derivation of
the proposed IDLH value for peracetic acid. This includes a detailed
summary of the health hazards of acute exposure to high airborne
concentrations of peracetic acid and the rationale for the proposed
IDLH value for peracetic acid.
To facilitate the review of this draft document, NIOSH requests
that the following questions be taken into consideration:
1. Does this document clearly outline the health hazards associated
with acute (or short-term) exposures to peracetic acid? If not, what
specific information is missing from the document?
2. Are the rationale and logic behind the derivation of an IDLH
value for peracetic acid clearly explained? If not, what specific
information is needed to clarify the basis of the IDLH value?
[[Page 53148]]
3. Are the conclusions supported by the data?
4. Are the tables clear and appropriate?
5. Is the document organized appropriately? If not, what
improvements are needed?
6. Are you aware of any scientific data reported in governmental
publications, databases, peer-reviewed journals, or other sources that
should be included within this document?
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2016-19051 Filed 8-10-16; 8:45 am]
BILLING CODE 4163-19-P
